Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jessica K. Ortwine & Kavita Bhavan. (2018) Morbidity, mortality, and management of methicillin-resistant S. aureus bacteremia in the USA: update on antibacterial choices and understanding. Hospital Practice 46:2, pages 64-72.
Read now
Read now
Carlota Gudiol, Guillermo Cuervo, Evelyn Shaw, Miquel Pujol & Jordi Carratalà. (2017) Pharmacotherapeutic options for treating Staphylococcus aureus bacteremia. Expert Opinion on Pharmacotherapy 18:18, pages 1947-1963.
Read now
Read now
Mickala M. Thompson & Ali Hassoun. (2017) Successful salvage treatment of native valve Enterococcus faecalis infective endocarditis with telavancin: two case reports. Infectious Diseases 49:7, pages 540-544.
Read now
Read now
Articles from other publishers (25)
Shio-Shin Jean, I-Min Liu, Po-Chuen Hsieh, Dai-Huang Kuo, Yi-Lien Liu & Po-Ren Hsueh. (2023) Off-label use versus formal recommendations of conventional and novel antibiotics for the treatment of infections caused by multidrug-resistant bacteria. International Journal of Antimicrobial Agents 61:5, pages 106763.
Crossref
Crossref
Ivan Tonna & Antonella Pia Tonna. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
64
99
.
Brandon Garcia, Jimmy Gonzalez & Saira Chaudhry. (2021) Clinical Outcomes for Telavancin for Salvage Therapy in Methicillin-resistant Staphylococcus Aureus Bacteremia. Infectious Diseases in Clinical Practice 29:6, pages e385-e389.
Crossref
Crossref
Annemieke Bloem, Hannelore I. Bax, Erlangga Yusuf & Nelianne J. Verkaik. (2021) New-Generation Antibiotics for Treatment of Gram-Positive Infections: A Review with Focus on Endocarditis and Osteomyelitis. Journal of Clinical Medicine 10:8, pages 1743.
Crossref
Crossref
Marisa Holubar, Lina Meng, William Alegria & Stan Deresinski. (2020) Bacteremia due to Methicillin-Resistant Staphylococcus aureus. Infectious Disease Clinics of North America 34:4, pages 849-861.
Crossref
Crossref
Temi Lampejo. (2020) Dalbavancin and telavancin in the treatment of infective endocarditis: a literature review. International Journal of Antimicrobial Agents 56:3, pages 106072.
Crossref
Crossref
Joseph Reilly, Micah A. Jacobs, Bruce Friedman, Kerry O. Cleveland, David A. Lombardi & Bibiana Castaneda-Ruiz. (2020) Clinical Experience with Telavancin for the Treatment of Patients with Bacteremia and Endocarditis: Real-World Results from the Telavancin Observational Use Registry (TOUR™). Drugs - Real World Outcomes 7:3, pages 179-189.
Crossref
Crossref
Marcus R. Pereira & Meenakshi M. Rana. (2019)
Methicillin‐resistant
Staphylococcus aureus
in solid organ transplantation—Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
. Clinical Transplantation 33:9.
Crossref
Crossref
Liang Li, Michael R. Yeaman, Arnold S. Bayer & Yan Q. Xiong. (2019) Phenotypic and Genotypic Characteristics of Methicillin-Resistant Staphylococcus aureus (MRSA) Related to Persistent Endovascular Infection. Antibiotics 8:2, pages 71.
Crossref
Crossref
Leonard R. Duncan, Robert K. Flamm, Helio S. Sader & Rodrigo E. Mendes. (2019) In vitro activity of telavancin against Staphylococcus aureus causing pneumonia or skin and skin structure infections with concomitant bloodstream infections in United States hospitals (2012–2016). Diagnostic Microbiology and Infectious Disease 93:2, pages 167-170.
Crossref
Crossref
Ryan L. Crass, Kelsey L. Powell & Angela M. Huang. (2019) Daptomycin for the treatment of Staphylococcus aureus infections complicated by septic pulmonary emboli. Diagnostic Microbiology and Infectious Disease 93:2, pages 131-135.
Crossref
Crossref
Kordo Saeed, Abhijit M. Bal, Ian M. Gould, Michael Z. David, Matthew Dryden, Efthymia Giannitsioti, Karolin Hijazi, Jessica A. Meisner, Silvano Esposito, Francesco Scaglione, Pierre Tattevin & Andreas Voss. (2019) An update on Staphylococcus aureus infective endocarditis from the International Society of Antimicrobial Chemotherapy (ISAC). International Journal of Antimicrobial Agents 53:1, pages 9-15.
Crossref
Crossref
Paul O. Lewis, Emily L. Heil, Kelly L. Covert & David B. Cluck. (2018)
Treatment strategies for persistent methicillin‐resistant
Staphylococcus aureus
bacteraemia
. Journal of Clinical Pharmacy and Therapeutics 43:5, pages 614-625.
Crossref
Crossref
Megumi Yazaki, Takehiko Oami, Kazuya Nakanishi, Ryota Hase & Hiroyuki Watanabe. (2018) A successful salvage therapy with daptomycin and linezolid for right-sided infective endocarditis and septic pulmonary embolism caused by methicillin-resistant Staphylococcus aureus. Journal of Infection and Chemotherapy 24:10, pages 845-848.
Crossref
Crossref
Louis D. Saravolatz, Kerry O. Cleveland, Khalid Rikabi, Ali Hassoun, Joseph Reilly, Leonard B. Johnson, Cedric Spak, Sharon Valenti & Susan Szpunar. (2018) A Retrospective Case Series of Telavancin for the Treatment of Staphylococcus aureus Bacteremia. Infectious Diseases in Clinical Practice 26:5, pages 264-269.
Crossref
Crossref
Andrew Wang, Jeffrey G. Gaca & Vivian H. Chu. (2018) Management Considerations in Infective Endocarditis. JAMA 320:1, pages 72.
Crossref
Crossref
Nicholas S Britt, Samad Tirmizi, David J Ritchie, Jeffrey E Topal, Dayna McManus, Victor Nizet, Ed Casabar & George Sakoulas. (2018) Telavancin for refractory MRSA bacteraemia in intermittent haemodialysis recipients. Journal of Antimicrobial Chemotherapy 73:3, pages 764-767.
Crossref
Crossref
Julie Harting, Francisco Fernandez, Rob Kelley, Tim Wiemken, Paula Peyrani & Julio Ramirez. (2017) Telavancin for the treatment of methicillin-resistant Staphylococcus aureus bone and joint infections. Diagnostic Microbiology and Infectious Disease 89:4, pages 294-299.
Crossref
Crossref
Jialing Lin, Chuanan Wu, Qianting Ou, Dongxin Lin, Ting Zhang, Chan Bai, Haoqu Zheng, Jiaping Ye, Xiaojie Wang, Ying Li, Xiaohua Ye & Zhenjiang Yao. (2017) Nasal colonization of Staphylococcus aureus colonal complex 5: Prevalence, influencing factors, and phenotypic and molecular characteristics in pregnant Chinese women. American Journal of Infection Control 45:10, pages 1106-1110.
Crossref
Crossref
Rohit Majumdar & Nancy F. Crum-Cianflone. (2017) Telavancin for MRSA Endocarditis. Infectious Diseases in Clinical Practice 25:4, pages 176-183.
Crossref
Crossref
Truc T. Tran, Vincent H. Tam, Barbara E. Murray, Cesar A. Arias & Kavindra V. Singh. (2017) Efficacy of Telavancin Alone and in Combination with Ampicillin in a Rat Model of Enterococcus faecalis Endocarditis. Antimicrobial Agents and Chemotherapy 61:6.
Crossref
Crossref
Michael Z. David & Robert S. Daum. 2017. Staphylococcus aureus. Staphylococcus aureus
325
383
.
Marisa Holubar, Lina Meng & Stan Deresinski. (2016) Bacteremia due to Methicillin-Resistant Staphylococcus aureus. Infectious Disease Clinics of North America 30:2, pages 491-507.
Crossref
Crossref
Ravina Kullar, George Sakoulas, Stan Deresinski & Sebastiaan J. van Hal. (2016) When sepsis persists: a review of MRSA bacteraemia salvage therapy. Journal of Antimicrobial Chemotherapy 71:3, pages 576-586.
Crossref
Crossref
Eric Wenzler & Keith A. Rodvold. (2015) Telavancin: The Long and Winding Road From Discovery to Food and Drug Administration Approvals and Future Directions. Clinical Infectious Diseases 61:suppl 2, pages S38-S47.
Crossref
Crossref